Morpholine → 4-(Cyanoacetyl)morpholine
Reaction equation
[C:1]([CH2:3][C:4]([OH:6])=O)#[N:2].[NH:7]1[CH2:12][CH2:11][O:10][CH2:9][CH2:8]1.O.ON1C2C=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC>CN(C)C=O.CN(C)C1C=CN=CC=1.C(OCC)(=O)C.O>[N:7]1([C:4](=[O:6])[CH2:3][C:1]#[N:2])[CH2:12][CH2:11][O:10][CH2:9][CH2:8]1Participants
9
Reactant 4
Product 1
Reagents, catalysts & solvents 4
Conditions
- Temperature
- 0 °C
Procedure
500 mg (5.88 mmol) Cyanoacetic acid are dissolved in 30 ml dimethylformamide, 563 mg (6.47 mmol) morpholine, 794 mg (5.88 mmol) 1-hydroxy-1H-benzotriazole hydrate and 718 mg (5.88 mmol) 4-dimethylaminopyridine are added. The reaction mixture is stirred at 0° C., then 1.12 g (5.88 mmol) 1-(3-dimethylaminopropyl)-3-ethylcarbodimide hydrochloride are added. The reaction mixture is stirred at room temperature for 18 hours, then water and ethyl acetate are added. The organic phase is dried over sodium sulfate and evaporated to dryness in vacuo. The residue is purified by preparative HPLC.
Workup
- stirringThe reaction mixture is stirred at room temperature for 18 hours
- dry with materialThe organic phase is dried over sodium sulfate
- customevaporated to dryness in vacuo
- customThe residue is purified by preparative HPLC
Sources & evidence
- ORD record
- ord-2d7ea12858164a89a916edabe4b0cbc4
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07691854B2
Reaction notes
Loading…